CWBR

CohBar (CWBR)

CohBar Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CWBR

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/11/28	08 : 05	Business Wire	CohBar, Inc.: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (Form 8-K)	NASDAQ:CWBR	CohBar Inc
2023/11/28	07 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CWBR	CohBar Inc
2023/11/13	23 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CWBR	CohBar Inc
2023/11/01	22 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CWBR	CohBar Inc
2023/10/25	22 : 01	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:CWBR	CohBar Inc
2023/10/25	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CWBR	CohBar Inc
2023/10/07	05 : 13	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:CWBR	CohBar Inc
2023/10/07	05 : 11	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:CWBR	CohBar Inc
2023/10/04	22 : 14	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:CWBR	CohBar Inc
2023/10/04	22 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CWBR	CohBar Inc
2023/09/13	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:CWBR	CohBar Inc
2023/09/13	05 : 47	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:CWBR	CohBar Inc
2023/09/13	02 : 44	Edgar (US Regulatory)	Form S-4/A - Registration of securities, business combinations: [Amend]	NASDAQ:CWBR	CohBar Inc
2023/08/15	05 : 07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CWBR	CohBar Inc
2023/08/15	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CWBR	CohBar Inc
2023/08/15	05 : 01	GlobeNewswire Inc.	CohBar Reports Second Quarter 2023 Financial Results	NASDAQ:CWBR	CohBar Inc
2023/08/11	06 : 30	Edgar (US Regulatory)	Form S-4/A - Registration of securities, business combinations: [Amend]	NASDAQ:CWBR	CohBar Inc
2023/06/05	21 : 05	GlobeNewswire Inc.	Morphogenesis, Inc. and CohBar, Inc. Announce Positive Results from Phase 1b Trial of IFx-Hu2.0, a Novel Personalized Cancer Vaccine, in Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) and Cutaneous Squamous Cell Carcinoma (cSCC)	NASDAQ:CWBR	CohBar Inc
2023/06/01	05 : 51	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CWBR	CohBar Inc
2023/05/30	21 : 05	GlobeNewswire Inc.	Morphogenesis, Inc. and CohBar, Inc. Announce Acceptance of Abstract for Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:CWBR	CohBar Inc
2023/05/23	20 : 56	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:CWBR	CohBar Inc
2023/05/23	20 : 30	GlobeNewswire Inc.	CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy	NASDAQ:CWBR	CohBar Inc
2023/05/15	21 : 33	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CWBR	CohBar Inc
2023/04/28	22 : 01	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:CWBR	CohBar Inc
2023/03/10	06 : 12	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:CWBR	CohBar Inc
2023/02/08	23 : 01	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CWBR	CohBar Inc
2023/02/08	23 : 01	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CWBR	CohBar Inc
2022/12/07	23 : 00	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CWBR	CohBar Inc
2022/11/17	22 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CWBR	CohBar Inc
2022/11/09	06 : 46	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CWBR	CohBar Inc